Blue Horseshoe Stocks: Options Recap, Form-4’s

Campbell Soup Co. CPB

After Campbell’s beat on earnings, we formulated an options idea in yesterday’s premarket report to go along with the activity we were observing. Our targets were the CPB Weekly $38.50-40.50 Calls, and despite a down day for the markets in general, CPB produced just the right performance to allow for some really nice gains.

Every single one of the five contracts contained within our designated range produced a big opportunity for quick profits.

$38.50 Calls – Range: 1.50-2.94 – Max Gain: 96%
$39 Calls – Range: .91-2.52 – Max Gain: 177%
$39.50 Calls – Range: .83-2.05 – Max Gain: 147%
$40 Calls – Range: .55-1.80 – Max Gain: 227%
$40.50 Calls – Range: .40-1.40 – Max Gain: 250%
______

Fresh Options Idea:
ADSK Weekly $131-133 Calls


Form-4 Alerts

Aside from earnings-related options ideas, we also routinely scan for Form-4 submissions indicating insider buying on stocks that are at or near a relative low. We also look for stocks whose charts have large gaps to fill to the upside.

Both of the following stocks we’re placing on bottom watch here check all of those boxes, as you can see on the included side-by-side charts. We’ve also formed a corresponding options idea for both:

Zillow Group Inc. Z
01/18 $30-40 Calls

Coty, Inc. COTY 
01/18 $8-10 Calls


Extended Watchlist:
SGSI, INPX, FPAY, BJ, TAOP, NVLN, CREG, PAGS, CMCM, BZUN, NBEV

Blue Horseshoe Stocks: NLSN Update & More

Neilsen N.V. NLSN

One of the items of interest from our premarket report yesterday morning was a selection of options ideas, including the NLSN  09/21 $25-27 Calls. Despite being a longer-term set of ideas, with more than a month until expiration, it still paid instant single-session dividends.

$43 Calls – Range: .65-1.05 – Max Gain:  62%
$43.50 Calls – Range: .50-.70 – Max Gain: 40%
$44 Calls – Range: .33-.50 – Max Gain: 51%

The gains weren’t eye-popping but it was definitely a good start, with the NLSN chart still boasting a sizable gap to the upside which was only partially filled by yesterday’s activity. We’ll continue to monitor the situation.
___________

FRESH OPTIONS IDEAS:
The Home Depot, Inc. HD Weekly $196-197.50 Calls
Advance Auto Parts, Inc. AAP Weekly $145-155 Calls


Extended Watchlist:
GEVO, NANO, EYE, BZUN, TUR

Blue Horseshoe Stocks: Stellar Options Calls & More

Valeant Pharmaceuticals, Inc. VRX – Options Recap

In yesterday morning’s premarket report, we noted that VRX had been coming off of recent annual lows, had a beat on earnings, and was up considerably in early trading.

Our exact words were “We want to formulate an options idea to coincide with the increased activity and expected price action in a stock in this position. We’ve seen this sort of pattern many times before, and if things play out similarly here, the VRX Weekly $10.50-12 Calls could be in line to see considerable gains.” Things did play out similarly. We did indeed see considerable gains, and quite frankly, that’s an understatement.

As VRX itself traded from 10.57 to 12.43, our targeted options calls posted astronomical moves on the day, giving traders a chance to grab a piece of the following gains:

$10.50 Calls – Range: .40-.1.92 – Max Gain: 380%
$11 Calls – Range: .18-1.50 – Max Gain: 733%
$11.50 Calls – Range: .08-1.05 – Max Gain: 1212%
$12 Calls – Range: .02-.74 – Max Gain: 3600%

This wasn’t even the first percentage gain in the thousands that we’ve rooted out in the past week. The SPY Weekly $238-50-239.50 Calls that we highlighted in Friday morning’s premarket report yielded a 4600% gainer on that day. Both of these plays serve as perfect examples of why we don’t limit our daily reports to stocks alone.


Cleantech Solutions International, Inc. CLNT

We did have a very nice play on the stock side of things as well yesterday, after we tagged CLNT in our extended watchlist. It ended up making a solid early push from a low of 4.11, and ran as high as 6.99 inside the first hour of trading.

That was good for intraday gains of up to 70% which we feel is quite good for a stock in this price range. CLNT is pulling back in premarket, but we will remain interested in possible bounce activity in the event that it holds support above yesterday’s swing low.



Proteon Therapeutics, Inc. PRTO

There’s an interesting situation unfolding with PRTO that warrants placing the stock on watch today. Despite reporting Q1 losses of $6.5M, the stock is gapping up heavily on the strength of a concurrent announcement. It pertains to the fact that the company’s investigatory treatment, vonapanitase, has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA).

Whenever such FDA news hits wires the resultant activity on the chart is sure to be interesting, which is evidenced by the the fact that traders are ignoring the disappointing quarterly figures that coincided with this event. Thus we are eager to track PRTO as we head through midweek.


Extended Watchlist:
ASTI, BZUN, LBIO, AAXN, ARGS, MTBC, REXX